oxazoles has been researched along with gt0918 in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 7 (87.50) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, Y; Gao, C; Ge, Z; Gong, W; He, S; Huang, X; Shan, L; Tong, Y; Wang, Y; Yang, M | 1 |
| Gu, Y; He, M; Peng, Y; Qu, F; Sun, J; Wang, G; Wang, Q; Zhou, F | 1 |
| Chen, C; Gao, X; Hou, J; Ren, S; Sun, Y; Wang, F; Wang, M; Xu, C; Xu, W; Yan, H; Yang, B; Yang, Q; Zhang, W; Zhou, Q; Zhou, T | 1 |
| Gu, S; Peng, Y; Sang, H; Sun, J; Wang, G; Wang, Y; Zhong, Y | 1 |
| Cadegiani, F; Goren, A; Lin, EM; Wambier, CG | 1 |
| Dong, X; Jiang, H; Li, H; Liu, Y; Ma, L; Meng, L; Ran, R; Song, G; Sun, Y; Tong, Y; Wang, M; Yan, H; Zhang, J; Zhang, R; Zhou, Q | 1 |
| Chen, J; Cheng, Q; Fang, Z; Jia, Q; Zhao, G | 1 |
| Fan, J; Fang, H; Jia, YC; Ju, MJ; Wang, H; Wang, XD; Yang, DW | 1 |
2 review(s) available for oxazoles and gt0918
| Article | Year |
|---|---|
Efficacy and safety of current medications for treating severe and non-severe COVID-19 patients: an updated network meta-analysis of randomized placebo-controlled trials.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azetidines; COVID-19; COVID-19 Drug Treatment; Humans; Imatinib Mesylate; Immunologic Factors; Network Meta-Analysis; Oxazoles; Purines; Pyrazoles; SARS-CoV-2; Severity of Illness Index; Sulfonamides; Thiohydantoins; Treatment Outcome | 2021 |
Proxalutamide for the treatment of COVID-19 rebound following Paxlovid treatment: Report of four cases and review of the literature.
Topics: COVID-19; Humans; Oxazoles | 2023 |
2 trial(s) available for oxazoles and gt0918
| Article | Year |
|---|---|
Preclinical profile and phase I clinical trial of a novel androgen receptor antagonist GT0918 in castration-resistant prostate cancer.
Topics: Aged; Animals; Apoptosis; Cell Proliferation; Follow-Up Studies; Humans; Male; Maximum Tolerated Dose; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Oxazoles; Prognosis; Prostatic Neoplasms, Castration-Resistant; Thiohydantoins; Tissue Distribution; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2020 |
Activity of preclinical and phase I clinical trial of a novel androgen receptor antagonist GT0918 in metastatic breast cancer.
Topics: Androgen Receptor Antagonists; Animals; Breast Neoplasms; Female; Humans; Mice; Oxazoles; Receptors, Androgen; Thiohydantoins | 2021 |
4 other study(ies) available for oxazoles and gt0918
| Article | Year |
|---|---|
Microenvironmental pH-modified solid dispersions to enhance the dissolution and bioavailability of poorly water-soluble weakly basic GT0918, a developing anti-prostate cancer drug: preparation, characterization and evaluation in vivo.
Topics: Animals; Animals, Inbred Strains; Antineoplastic Agents; Biological Availability; Cinnamates; Citric Acid; Dogs; Drug Compounding; Drugs, Investigational; Excipients; Fumarates; Hydrogen-Ion Concentration; Imidazoles; Male; Nitriles; Oxazoles; Povidone; Prostatic Neoplasms; Random Allocation; Solubility; Succinic Acid; Suspensions; Tablets; Thiohydantoins | 2014 |
Metabolomic profiling to evaluate the efficacy of proxalutamide, a novel androgen receptor antagonist, in prostate cancer cells.
Topics: Amino Acids; Androgen Receptor Antagonists; Anilides; Benzamides; Cell Line, Tumor; Cell Survival; Glutathione; Humans; Male; Metabolome; Metabolomics; Nitriles; Nucleosides; Oxazoles; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Thiohydantoins; Tosyl Compounds | 2020 |
Quantitative determination of proxalutamide in rat plasma and tissues using liquid chromatography/tandem mass spectrometry.
Topics: Animal Structures; Animals; Biological Availability; Chromatography, High Pressure Liquid; Humans; Male; Oxazoles; Plasma; Prostatic Neoplasms; Rats; Rats, Sprague-Dawley; Tandem Mass Spectrometry; Thiohydantoins; Tissue Distribution | 2021 |
Potential risk for developing severe COVID-19 disease among anabolic steroid users.
Topics: Adult; Anabolic Agents; Androgen Antagonists; COVID-19 Drug Treatment; Disease Progression; Humans; Male; Oxandrolone; Oxazoles; Performance-Enhancing Substances; SARS-CoV-2; Severity of Illness Index; Thiohydantoins | 2021 |